Cargando…
Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
OBJECTIVE: To explore the effect of dapagliflozin on cardiac function, inflammation, and cardiovascular outcome in patients with ST-segment elevation myocardial infarction (STEMI) combined with type 2 diabetes (T2DM) after percutaneous coronary intervention (PCI). METHODS: 70 patients with STEMI and...
Autores principales: | Xue, LiMing, Yuan, Xian, Zhang, Shuguang, Zhao, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536432/ https://www.ncbi.nlm.nih.gov/pubmed/34691230 http://dx.doi.org/10.1155/2021/9388562 |
Ejemplares similares
-
Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Dapagliflozin improves cardiovascular risk factors in Emirati
patients with T2DM
por: Nada, Aml Mohamed, et al.
Publicado: (2021) -
Unrecognized perforation into the anterior interventricular vein complicating PCI for anterior STEMI: An unexpected detour
por: Rothstein, Eric S., et al.
Publicado: (2021) -
Prognostic implications and outcomes of cardiac arrest among contemporary patients with STEMI treated with PCI
por: Kumar, Anirudh, et al.
Publicado: (2021) -
The abnormal level and prognostic potency of multiple inflammatory cytokines in PCI‐treated STEMI patients
por: Zhang, Jing, et al.
Publicado: (2022)